Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans ...

NEW DELHI -More than 80 per cent of Indian patients carry multidrug-resistant organisms (MDROs), the highest globally, according to an alarming study released on November 18. This reflects the deep ...

Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactam Fosmanogepix second phase 3 study ...

The sexually transmitted disease has become increasingly resistant to existing antibiotics. By Andrew Jacobs The Food and Drug Administration has approved two new antibiotics for the treatment of ...

Antibiotics can help treat certain types of colitis, such as infectious colitis. They may also help manage complications of other types of colitis. While more research is necessary, antibiotics may ...

Healthcare-associated infections (HAIs) constitute the most frequent adverse events in the context of health service delivery. These infections, when caused by multidrug-resistant (MDR) pathogens, may ...

GSK and Spero Therapeutics have shared phase 3 results on their antibiotic candidate, revealing that the oral therapy closely matched the intravenous incumbent in a trial that could support filings ...

As "superbugs" continue to surge, the World Health Organization is now warning that one in every six bacterial infections are resistant to antibiotics. WHO also called for antibiotic medications to be ...

ABSTRACT: The emergence and spread of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is a significant public health problem. The digestive carriage of ESBL-producing ...